The healthcare sector in the United States is currently undergoing a monumental transformation, driven by the rapid maturation of biological therapies. As of 2026, the US Regenerative Medicine Market has transitioned from an experimental frontier into a cornerstone of modern clinical practice. This shift is largely propelled by the integration of artificial intelligence in cell characterization...
English